Fed Holds Rates Steady, Punts on Middle East Risk Outlook
The Federal Reserve keeps policy unchanged as global tensions weigh on growth and inflation prospects. The move delay...
Volatility Metrics Dividend Aristocrats Etf
This section highlights volatility metrics for the dividend aristocrats ETF, offering key indicators to monitor risk and potential entry points.
22,062 articles
State Street Strategist Still Sees 3 Rate Cuts in 2026
A State Street strategist says the Fed will cut rates three times in 2026, a view that clashes with current market pr...
Webull Cash Bonuses in March 2026: Market Update Today
Webull rolled out a March 2026 cash-bonuses program, offering tiered deposit matches and a first-transfer reimburseme...
Three Asias, Three Different Playbooks Drive PepsiCo
PepsiCo unveils a landmark Asia strategy, reframing markets into three asias, three different playbooks to capture gr...
Amazon Stock Price Prediction: 2026–2030 Outlook for AMZN
Amazon shares navigate a shifting tech landscape in 2026 as analysts map a path from near-term growth to a longer-ter...
Are These Tesla Competitors Buys Worth a Look in 2026?
As the EV race heats up in 2026, investors are weighing which rivals to buy. This guide breaks down the top contender...
Soaring Fertilizer Prices Could Strain U.S. Farms in 2026
Global fertilizer supply disruptions push prices higher, threatening farm budgets and consumer costs in the United St...
Paysign (PAYS) 2025 Earnings: Q4 Insights for Investors
Paysign's 2025 earnings paint a picture of a niche fintech player balancing steady card-services revenue with new par...
Trump's Attacks on Offshore Wind Endanger Infrastructure
Rising political rhetoric around offshore wind threatens U.S. infrastructure spending, risking delays and higher cost...
UBS Lifts Industries $140 Price Target as Urea Rally Surges
UBS lifts industries $140 price target on CF Industries as nitrogen markets tighten amid supply disruptions. The move...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
The Retirement Risk Most Financial Advisors Don’t Warn About
As markets wobble in 2026, retirees face hidden costs from withdrawal sequencing and tax drag that quietly erode life...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status